Aspergillosis Clinical Trials Aspergillosis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection
Conditions:   Cystic Fibrosis;   Aspergillosis Interventions:   Drug: Posaconazole 100 MG [Noxafil];   Drug: Posaconazole 40 MG/ML Sponsors:   Bambino Gesù Hospital and Research Institute;   University of Exeter;   Radboud University;   Consorzio per Valutazioni Biologiche e Farmacologiche Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2021 Category: Research Source Type: clinical trials